|
| | n = 101 (100%) |
|
| Patient demographics |
| Age (y), median (IQR) | 60 (52–67) |
| Sex, male : female (count, %) | 47 (46.5):54 (53.5) |
| Body mass index (kg/m²), median (IQR) | 24.6 (21.7–27.5) |
| MELD score, median (IQR) | 9 (7–14) |
| eGFR <90 mL/min/1.73 m², count (%) | 18 (17.8) |
|
| ALBI score (count, %) |
| ALBI 1 score | 30 (29.7) |
| ALBI 2 score | 46 (45.5) |
| ALBI 3 score | 22 (21.8) |
| Unknown | 3 (3) |
|
| ASA score (count, %) |
| ASA I | 2 (2) |
| ASA II | 74 (73.3) |
| ASA III | 25 (24.8) |
|
| Past medical history |
| Preoperative biliary drainage, count (%) | 29 (28.7) |
| Endoscopic | 18 |
| Percutaneous | 6 |
| Surgical | 5 |
| Previous history of cholangitis, count (%) | 8 (7.9) |
| Number of RBC packs transfused†, median (IQR) | 0 (0-1) |
|
| Preoperative laboratory tests |
| Haemoglobin (g/L), median (IQR) | 115 (107–126) |
| Platelet count (109/L), median (IQR) | 285 (242–381) |
| International Normalized Ratio, median (IQR) | 1.07 (1.02–1.16) |
| Prothrombin time (sec), median (IQR) | 12.9 (11.8–14.5) |
| Serum total bilirubin (µmol/L), median (IQR) | 22.1 (12–101.4) |
| Serum glucose (µmol/L), median (IQR) | 5.1 (4.7–5.6) |
| Serum creatinine (µmol/L), median (IQR) | 55 (47–66) |
| Serum albumin (g/L), median (IQR) | 37 (32–41) |
| Serum CA 19-9 (IU/mL), median (IQR) | 22.2 (9.7–91.4) |
|
